Conduit Pharmaceuticals (CDT) had the highest return between September 1, 2023 and February 29, 2024 by a US stock, returning 282,835.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Conduit Pharmaceuticals (CDT) | 9/1/2023 - 2/29/2024 | 282,835.89% |
COSCIENS Biopharma (CSCI) | 9/1/2023 - 2/29/2024 | 1,900.5% |
Diversified Energy (DEC) | 9/1/2023 - 2/29/2024 | 1,005.7% |
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) | 9/1/2023 - 2/29/2024 | 915.03% |
Soleno Therapeutics (SLNO) | 9/1/2023 - 2/29/2024 | 874.19% |
Treasure Global (TGL) | 9/1/2023 - 2/29/2024 | 847.65% |
Direct Digital (DRCT) | 9/1/2023 - 2/29/2024 | 762.02% |
Lixiang Education (LXEH) | 9/1/2023 - 2/29/2024 | 751.06% |
Mobix Labs (MOBXW) | 9/1/2023 - 2/29/2024 | 736.36% |
LMF Acquisition Opportunities (ICUCW) | 9/1/2023 - 2/29/2024 | 712.96% |
SoundHound AI (SOUNW) | 9/1/2023 - 2/29/2024 | 709.09% |
Nkarta (NKTX) | 9/1/2023 - 2/29/2024 | 594.25% |
Tempest Therapeutics (TPST) | 9/1/2023 - 2/29/2024 | 593.46% |
enGene Holdings Inc Warrants (ENGNW) | 9/1/2023 - 2/29/2024 | 481.34% |
Viking Therapeutics (VKTX) | 9/1/2023 - 2/29/2024 | 454.32% |
NewAmsterdam Pharma Company NV Warrant (NAMSW) | 9/1/2023 - 2/29/2024 | 439.5% |
Applied Therapeutics (APLT) | 9/1/2023 - 2/29/2024 | 435.34% |
Alarum Technologies (ALAR) | 9/1/2023 - 2/29/2024 | 414.71% |
Sera Prognostics (SERA) | 9/1/2023 - 2/29/2024 | 403.95% |
Sky Harbour Group Corporation WT (SKYH.WT) | 9/1/2023 - 2/29/2024 | 402.87% |
Lexaria Bioscience (LEXXW) | 9/1/2023 - 2/29/2024 | 382.8% |
EUDA Health (EUDAW) | 9/1/2023 - 2/29/2024 | 378.73% |
Altimmune (ALT) | 9/1/2023 - 2/29/2024 | 376.38% |
Mersana Therapeutics (MRSN) | 9/1/2023 - 2/29/2024 | 373.04% |
Swvl (SWVL) | 9/1/2023 - 2/29/2024 | 363% |
